T0	Participants 262 390	to what extent the percentage of prostate cancers (PCs) detected in men with these suspicious findings varies between examiners.
T1	Participants 500 663	7,280 men underwent a PSA-determination and DRE of whom 2,102 underwent prostate biopsy (biopsy indication PSA > or = 4.0 ng/ml and/or suspicious DRE and/or TRUS).
T2	Participants 1050 1103	2,102 men biopsied, 443 PCs were detected (PPV = 21%)
T3	Participants 1224 1249	men with a suspicious DRE